Back to top
more

Adient (ADNT)

(Real Time Quote from BATS)

$28.25 USD

28.25
267,763

-0.61 (-2.11%)

Updated May 21, 2024 02:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (142 out of 248)

Industry: Automotive - Original Equipment

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

New Strong Sell Stocks for May 21st

by Zacks Equity Research

DDD, ADNT and ALGT have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2024.

Adient (ADNT) Q2 Earnings Beat Estimates, Guidance Revised

by Zacks Equity Research

Adient (ADNT) reports mixed fiscal second-quarter results and expects fiscal 2024 revenues in the range of $14.8-$14.9 billion, down from the previous guidance of $15.40-$15.50 billion.

New Strong Sell Stocks for May 13th

by Zacks Equity Research

AESI, AEG and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2024.

Adient (ADNT) International Revenue Performance Explored

by Zacks Equity Research

Review Adient's (ADNT) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Compared to Estimates, Adient (ADNT) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Adient (ADNT) Beats Q2 Earnings Estimates

by Zacks Equity Research

Adient (ADNT) delivered earnings and revenue surprises of 38.46% and 2.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Adient (ADNT) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Autoliv, Inc. (ALV) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Autoliv (ALV) delivered earnings and revenue surprises of 12.86% and 1.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Is Adient (ADNT) Up 5.1% Since Last Earnings Report?

by Zacks Equity Research

Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Adient (ADNT) Q1 Earnings Miss Estimates, Guidance Revised

by Zacks Equity Research

Adient (ADNT) reports lower-than-expected first-quarter results and envisions fiscal 2024 revenues in the range of $15.40-$15.50 billion, down from the previous guidance of $15.60-$15.70 billion.

Adient (ADNT) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

What Analyst Projections for Key Metrics Reveal About Adient (ADNT) Q1 Earnings

by Zacks Equity Research

Evaluate the expected performance of Adient (ADNT) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

BorgWarner (BWA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

by Zacks Equity Research

BorgWarner (BWA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Adient (ADNT) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Allison (ALSN) Partners SANY for Mining Transmission Solutions

by Zacks Equity Research

The collaboration positions Allison (ALSN) as a key supplier of transmissions for SANY's lineup of mining vehicles and heralds a new era of innovation and efficiency in the mining industry.

New Strong Sell Stocks for December 12th

by Zacks Equity Research

ADNT, ATSG and NGLOY have been added to the Zacks Rank #5 (Strong Sell) List on December 12, 2023.

Why Is Adient (ADNT) Up 9.2% Since Last Earnings Report?

by Zacks Equity Research

Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is the Options Market Predicting a Spike in Adient (ADNT) Stock?

by Zacks Equity Research

Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.

Adient (ADNT) Q4 Earnings Miss Estimates & Contract Y/Y

by Zacks Equity Research

Adient (ADNT) envisions fiscal 2024 revenues in the range of $15.60-15.70 billion, up from $15.40 billion recorded in fiscal 2023.

Adient (ADNT) Reports Q4 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Adient (ADNT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Stay Ahead of the Game With Adient (ADNT) Q4 Earnings: Wall Street's Insights on Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Adient (ADNT) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Adient (ADNT) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Buy Adient (ADNT) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Visteon (VC) Q3 Earnings Top Estimates

by Zacks Equity Research

Visteon (VC) delivered earnings and revenue surprises of 26.34% and 3.33%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?